The Cancer Letter

Inside information on cancer research and drug development

Menthol ban has been a no-brainer for decades—will it finally happen?

In Brief

Chanita Hughes-Halbert named associate director for cancer equity at USC Norris
MD Anderson, Syntropy enter into a system technology agreement
ASCO-ACCC piloting test tools to diversify cancer clinical trials
Naiyer Rizvi named CMO of Synthekine
Pearl McElfish named associate director of community outreach and engagement at UAMS Winthrop P. Rockefeller Cancer Institute
Pitt and IU researchers study cognitive dysfunction after chemotherapy

Drugs & Targets

Keytruda receives FDA Accelerated Approval for HER2-positive gastric cancer
Tibsovo sNDA receives FDA acceptance and Priority Review for IDH1-mutated cholangiocarcinoma
Opdivo sBLA receives FDA acceptance and Priority Review for adjuvant treatment for patients with muscle-invasive urothelial carcinoma
Xtandi approved by European Commission for men with metastatic hormone-sensitive prostate cancer
Janssen submits Marketing Authorization Application to EMA seeking approval of cilta-cel for relapsed and/or refractory multiple myeloma
Zynlonta receives FDA accelerated approval for large B-cell lymphoma

In The Clinic

Trials & Tribulations

Best practices in preventing heartbreak:
A look at a SWOG cancer control trial

Best practices in preventing heartbreak: A look at a SWOG cancer control trial
Setting a research agenda on cannabis and cannabinoids: Updates from the NCI symposium A look at a SWOG cancer control trial
Trials & Tribulations
City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation
FreeTrials & Tribulations
The Delaware experience:
FreeTrials & Tribulations
Tackling racial disparities through novel approaches to engage communities in research Keeping in contact with those at risk is key to colorectal and breast cancer screening during COVID-19
FreeTrials & Tribulations

Latest Issue

Read the latest issue

UPCOMING EVENTS

No post found

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Looking for IP Login?